• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CVS Health Helps Improve Access to More Affordable Fertility Treatments

    10/16/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $CVS alert in real time by email

    WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations.

    CVS Health (PRNewsFoto/CVS Health)

    CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (IVF) drug to bring the price of the medicine down by 84%. 

    CVS Specialty Pharmacy has a team of dedicated specialist pharmacists focused on fertility treatments, helping people use treatments safely and effectively. In addition, CVS Specialty Pharmacy will help people understand their fertility benefit and assess their financial options.

    "Fertility medications often require special administration and high-touch expertise. We are proud to join the President to help make every step of the journey as simple as possible for families by providing nationwide access," said Lucille Accetta, RPh, Senior Vice President and Chief Pharmacy Officer, CVS Health. "We are committed to being America's most trusted health care company as we strive to continually improve affordability and access to medicine for families everywhere.

    "We are uniquely built to help deliver solutions like this with our clinical specialization, convenient locations, and ability to help people navigate to the lowest possible cost. As the Administration looks to provide more affordable fertility treatments to all Americans, CVS Specialty has the expertise in fertility and the industry relationships to deliver on the promise of the TrumpRx solution."

    Today's announcement represents another example of how CVS Health is expanding affordability for customers by leveraging its strengths in pharmacy and improving access through multiple delivery channels in healthcare, as CVS Health also done with GLP-1 drugs.

    When will the TrumpRx Fertility program be available?

    • We anticipate the program will be available in January 2026. As we near the launch date, we will provide additional information on how to use the platform to access fertility medicines.

    What drugs are included in TrumpRx Fertility program? 

    • Gonal-F will offer a more competitive price on the TrumpRx platform. Because the program will not launch until 2026, there may be changes to which drugs and which manufacturers will support competitive cash rates through this platform. 

    What are the benefits for patients?

    • Because there is often and urgency to fertility cycles, such as IVF, this program will expedite the pharmacy process for patients needing to access IVF medications. Rather than pharmacy shopping, the patient can access one set price for Gonal-F through the TrumpRx Fertility program. 

    How does CVS Specialty Pharmacy help families?

    CVS Specialty Pharmacy works closely with families, doctors, and insurance plans from the start. You can count on us for:

    • Complimentary pre-verification: We'll review your medication plan to verify what's covered before you start, so you and your doctor can make the best financial choice.
    • Financial assistance: If you don't have fertility medication benefits, we'll help you find out if you're eligible for immediate savings.
    • Claims support: We'll file your insurance claims for you and help make sure you get the most from your fertility coverage while minimizing your costs.

    Just like your doctor is a specialist in fertility treatment, we're specialists in fertility treatment medications and we offer more personalized support. We can:

    • Advise on correct therapy usage
    • Help manage side effects
    • Assist with injection-related issues
    • Coordinate care with your doctor
    • Answer your questions
    • Arrange egg donor therapy medications

    Our pharmacists are dedicated to fertility treatment, so you'll have support and guidance from specialists who help people through it every day. Your pharmacist-led CareTeam takes an active role in your care to make sure you have the help you need day and night. You can depend on us to make it all simpler for you.

    Most specialty pharmacies only deliver, but with CVS Specialty Pharmacy, we make it as convenient as possible to get the fertility medications and supplies you need when you need them. We can have your medications available for pickup at any CVS Pharmacy, or your medicine can be delivered to your door. Choose the convenience of having your medication delivered by mail to your home, office, doctor's office or even a temporary address if you're traveling.

    We offer next-day service at no additional cost. It's one more way we help you stay on track with your treatment. Medication is delivered in discreet, temperature-controlled packaging.

    About CVS Health

    CVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics, and a leading pharmacy benefits manager with approximately 87 million plan members. The Company also serves an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including highly rated Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

    David Whitrap

    Vice President, External Affairs

    CVS Health

    857-523-1219

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-helps-improve-access-to-more-affordable-fertility-treatments-302586893.html

    SOURCE CVS Health

    Get the next $CVS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CVS

    DatePrice TargetRatingAnalyst
    3/12/2026$94.00Mkt Perform → Outperform
    Bernstein
    10/14/2025$91.00Buy
    Goldman
    8/18/2025$79.00Neutral → Buy
    UBS
    8/14/2025$82.00Neutral → Outperform
    Robert W. Baird
    2/13/2025$55.00 → $75.00Market Perform → Outperform
    Leerink Partners
    2/12/2025Neutral → Overweight
    Cantor Fitzgerald
    1/30/2025Hold → Buy
    Edward Jones
    12/3/2024$66.00Hold → Buy
    Deutsche Bank
    More analyst ratings

    $CVS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CVS Health upgraded by Bernstein with a new price target

    Bernstein upgraded CVS Health from Mkt Perform to Outperform and set a new price target of $94.00

    3/12/26 8:38:26 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Goldman initiated coverage on CVS Health with a new price target

    Goldman initiated coverage of CVS Health with a rating of Buy and set a new price target of $91.00

    10/14/25 8:48:20 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health upgraded by UBS with a new price target

    UBS upgraded CVS Health from Neutral to Buy and set a new price target of $79.00

    8/18/25 8:45:28 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Gallina John E

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    3/20/26 5:05:17 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 3 filed by new insider Gallina John E

    3 - CVS HEALTH Corp (0000064803) (Issuer)

    3/19/26 5:26:13 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    EVP, CPO and General Counsel Khichi Samrat S. covered exercise/tax liability with 7,886 shares, decreasing direct ownership by 21% to 29,775 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    3/2/26 5:53:29 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    SEC Filings

    View All

    CVS Health Corporation filed SEC Form 8-K: Leadership Update

    8-K - CVS HEALTH Corp (0000064803) (Filer)

    3/19/26 4:08:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 13F-HR filed by CVS Health Corporation

    13F-HR - CVS HEALTH Corp (0000064803) (Filer)

    2/13/26 4:07:56 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 10-K filed by CVS Health Corporation

    10-K - CVS HEALTH Corp (0000064803) (Filer)

    2/10/26 6:36:59 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and President, Aetna Nelson Steven H bought $1,289 worth of shares (24 units at $53.70) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    1/27/26 5:20:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    EVP and Chief People Officer Capozzi Heidi B bought $4,589 worth of shares (80 units at $57.36) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    10/14/25 7:08:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Sansone Guy P bought $100,009 worth of shares (1,570 units at $63.70), increasing direct ownership by 15% to 12,007 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/9/25 8:22:46 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CVS Pharmacy® celebrates opening of first pharmacy-only location in Chicago

    Small, dedicated neighborhood pharmacies to open in select communities to help increase access to convenient pharmacy care Openings are part of ongoing commitment to serve communities and meet consumers where they are WOONSOCKET, R.I., March 30, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today unveiled the first of nearly 20 pharmacy-only, apothecary-style CVS Pharmacy® locations it plans to open this year to increase access to pharmacy care. The new pharmacy, located at 2628 West Pershing Road in Chicago's West End, will help bridge gaps in care and make it easier for community members to access medications, immunizations and other health care services provided by pharmacists.

    3/30/26 12:00:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health declares quarterly dividend

    WOONSOCKET, R.I., March 18, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on May 4, 2026, to holders of record on April 23, 2026. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of December 31, 2025, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary c

    3/18/26 5:15:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health Foundation Invests $2.24 Million to Strengthen Community Health in Charlotte's Historic West End

    Health Zones effort aims to improve health care access, healthy food and chronic condition support in CharlotteCHARLOTTE, N.C., March 18, 2026 /PRNewswire/ -- The CVS Health Foundation today announced the launch of its Health Zone in Charlotte with a $2.24 million investment in the Westside Wellness Collab, led by Local Initiatives Support Corporation (LISC) Charlotte to expand access to health care, healthy food and chronic condition support in Charlotte's Historic West End. "Families deserve access to quality care, healthy food and the support networks that make long‑term well

    3/18/26 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Financials

    Live finance-specific insights

    View All

    CVS Health declares quarterly dividend

    WOONSOCKET, R.I., March 18, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on May 4, 2026, to holders of record on April 23, 2026. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of December 31, 2025, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary c

    3/18/26 5:15:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health Foundation Invests $2.24 Million to Strengthen Community Health in Charlotte's Historic West End

    Health Zones effort aims to improve health care access, healthy food and chronic condition support in CharlotteCHARLOTTE, N.C., March 18, 2026 /PRNewswire/ -- The CVS Health Foundation today announced the launch of its Health Zone in Charlotte with a $2.24 million investment in the Westside Wellness Collab, led by Local Initiatives Support Corporation (LISC) Charlotte to expand access to health care, healthy food and chronic condition support in Charlotte's Historic West End. "Families deserve access to quality care, healthy food and the support networks that make long‑term well

    3/18/26 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

    Fourth Quarter Highlights Total revenues increased to $105.7 billion, up 8.2% compared to prior yearGAAP diluted EPS of $2.30 and Adjusted EPS of $1.09Full-Year Highlights Total revenues increased to a record high $402.1 billion, up 7.8% compared to prior yearGAAP diluted EPS of $1.39 and Adjusted EPS of $6.75Generated cash flow from operations of $10.6 billionOperational Highlights CVS Pharmacy® successfully completed the transition to cost-based reimbursement across its Commercial, Third-Party Discount, Medicare and Medicaid businesses.Aetna® continues to improve the experience for health care professionals and their patients, approving more than 95% of all eligible prior authorizations wi

    2/10/26 6:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Leadership Updates

    Live Leadership Updates

    View All

    CVS Health Helps Improve Access to More Affordable Fertility Treatments

    WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (

    10/16/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Aetna 2026 Medicare Advantage plans deliver access to affordable, personalized care

    Providing access to affordable care $0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1, $0 copay for colonoscopies and mammograms at in-network providers$0 copay for annual Healthy Home Visit from a licensed Signify Health clinicianContinued investment in technology, tools and teams that support our members Commitment to supporting unique member needs — those living with chronic conditions and individuals dually eligible for both Medicare and MedicaidLeveraging the strength of the CVS Health family of companies to deliver differentiated member experiencesWOONSOCKET, R.I., Oct. 1, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced our 2026 Medi

    10/1/25 7:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health Announces Chief Financial Officer Transition Plan; Appoints Chief Medical Officer

    WOONSOCKET, R.I., April 8, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced two leadership updates. Brian Newman has been named executive vice president and chief financial officer designate, effective April 21. He will succeed current chief financial officer, Tom Cowhey, who will transition to serve as a strategic advisor to president and chief executive officer David Joyner, effective May 12.Amy Compton-Phillips, M.D., is the company's new executive vice president and chief medical officer, effective May 19, also reporting to David Joyner.Based on year-to-date res

    4/8/25 6:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CVS Health Corporation

    SC 13G - CVS HEALTH Corp (0000064803) (Subject)

    11/13/24 1:00:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by CVS Health Corporation (Amendment)

    SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)

    2/13/24 5:02:40 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by CVS Health Corporation (Amendment)

    SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)

    2/9/23 11:16:32 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples